Skip to main content
. 2018 Mar 13;7(4):1170–1182. doi: 10.1002/cam4.1424

Figure 3.

Figure 3

The calibration curves for predicting the 3‐year overall survival (OS, A, C, and E) and recurrence‐free survival (RFS, B, D, and F) rates by nomogram prediction and actual observation in patients with hepatocellular carcinoma in the primary (A and B), internal validation (C and D), and external validation cohorts (E and F).